Skip to main content

New system developed that can switch on immune cells to attack cancer cells

Researchers have developed an artificial structure that mimics the cell membrane, which can switch on immune cells to attack and destroy a designated target.  This method has potential to be used as a future cancer immunotherapy treatment as well as providing more insight into how immune cells are activated to find and kill cancer cells. The findings are presented today (07/12/2016) at the Joint Congress of the British and Dutch Societies for Immunology, taking place in Liverpool, UK.

Reason why farm kids develop fewer allergies explained

Scientists have discovered why growing up on a farm might protect children from developing allergies. Using studies in both mice and humans, they found that exposure to farm dust increases expression of a protective protein that suppresses the inflammatory immune system by modifying the communication between the lining of the lungs and the immune system. The findings are presented today (07/12/16) at the Joint Congress of the British and Dutch Societies for Immunology, taking place in Liverpool, UK.

Research Associate [Maternity Cover]

The Halim lab is actively recruiting highly talented and motivated scientists to join a vibrant and collaborative tumour immunology group within the University of Cambridge, CRUK Cambridge Institute. We are interested in understanding the role of innate lymphoid cells in regulating the immune response to cancer. Our long-term goal is to pharmacologically modulate the function of innate lymphoid cells with an aim to polarize the local immune environment towards an anti-cancer phenotype.

Postdoctoral Research Scientist in B cell immunology x2

Two Postdoctoral Research Scientist positions are available in the laboratory of Dr. Claudia Ribeiro de Almeida at the Babraham Institute in Cambridge UK. Current work in the Ribeiro de Almeida lab focuses on understanding how antibody diversity is regulated at the RNA level, by a class of RNA remodelling enzymes known as RNA helicases, and the role these mechanisms play in maintaining genome stability in B-lymphocytes.

Scientist - Immunology

The TB Vaccine Evaluation Group at the UK Health Security Agency (UKHSA) at Porton Down uses the non-human primate (NHP) model to assess the safety, efficacy and immunogenicity of a range of novel vaccines and therapeutics to protect against and treat Tuberculosis, a disease which was responsible for ~1.4 million deaths in 2019.

RSB Connect 2021: Bringing outreach and engagement into the future


Royal Society of Biology Connect 2021, on 23 – 25 November 2021 is a three-day online bioscience outreach and engagement symposium. The event will include talks, presentations, Q&A sessions and networking opportunities to provide training, information and discussion of contemporary issues relating to outreach and engagement.

This year's symposium will summarise what we have learned during the pandemic, what new tools have made life better and how we can utilise the lessons learned to enhance outreach and engagement work for the future.

UK-South Korea Health & Bioscience Webinar Series: COVID-19/Pandemic Preparedness


The MRC and MSIT/NRF are presenting a short series of online webinars to showcase excellent UK and South Korean science and highlight the benefits of collaboration. The first webinar will focus on COVID-19 and pandemic preparedness and is taking place at 8am-10.15am (UK), 4pm-6.15pm (KST) on 26 October 2021. Speakers include: